319 related articles for article (PubMed ID: 25816824)
21. Ethics in Canadian health technology assessment: a descriptive review.
DeJean D; Giacomini M; Schwartz L; Miller FA
Int J Technol Assess Health Care; 2009 Oct; 25(4):463-9. PubMed ID: 19845976
[TBL] [Abstract][Full Text] [Related]
22. Health technology assessment and primary data collection for reducing uncertainty in decision making.
Goeree R; Levin L; Chandra K; Bowen JM; Blackhouse G; Tarride JE; Burke N; Bischof M; Xie F; O'Reilly D
J Am Coll Radiol; 2009 May; 6(5):332-42. PubMed ID: 19394574
[TBL] [Abstract][Full Text] [Related]
23. CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN HEALTHCARE SYSTEM IN SLOVENIA.
Prevolnik Rupel V
Int J Technol Assess Health Care; 2017 Jan; 33(3):360-364. PubMed ID: 28434423
[TBL] [Abstract][Full Text] [Related]
24. Hospital-based health technology assessment (HTA) in Finland: a case study on collaboration between hospitals and the national HTA unit.
Halmesmäki E; Pasternack I; Roine R
Health Res Policy Syst; 2016 Apr; 14():25. PubMed ID: 27044400
[TBL] [Abstract][Full Text] [Related]
25. The value and consequences of using public health technology assessments for private payer decision-making in Canada: one size does not fit all.
Pericleous L; Amin M; Goeree R
J Med Econ; 2019 May; 22(5):478-487. PubMed ID: 30757934
[TBL] [Abstract][Full Text] [Related]
26. History of health technology assessment in Belgium.
Cleemput I; Van Wilder P
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():82-7. PubMed ID: 19500438
[TBL] [Abstract][Full Text] [Related]
27. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
Oortwijn W; Mathijssen J; Banta D
Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
[TBL] [Abstract][Full Text] [Related]
28. Health technology assessment and health care in the European Union.
Banta D; Oortwijn W
Int J Technol Assess Health Care; 2000; 16(2):626-35. PubMed ID: 10932427
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
30. HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.
Kahveci R; Koç EM; Küçük EÖ
Int J Technol Assess Health Care; 2017 Jan; 33(3):402-408. PubMed ID: 28595660
[TBL] [Abstract][Full Text] [Related]
31. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies.
Drummond M; Manca A; Sculpher M
Int J Technol Assess Health Care; 2005; 21(2):165-71. PubMed ID: 15921055
[TBL] [Abstract][Full Text] [Related]
32. TOWARD INTEGRATION IN THE CONTEXT OF HEALTH TECHNOLOGY ASSESSMENT: THE NEED FOR EVALUATIVE FRAMEWORKS.
van der Wilt GJ; Gerhardus A; Oortwijn W
Int J Technol Assess Health Care; 2017 Jan; 33(5):586-590. PubMed ID: 29256849
[TBL] [Abstract][Full Text] [Related]
33. Regional HTA in Italy: promising or confusing?
Garattini L; van de Vooren K; Curto A
Health Policy; 2012 Dec; 108(2-3):203-6. PubMed ID: 23141760
[TBL] [Abstract][Full Text] [Related]
34. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
Schwarzer R; Siebert U
Int J Technol Assess Health Care; 2009 Jul; 25(3):305-14. PubMed ID: 19619349
[TBL] [Abstract][Full Text] [Related]
35. The feasibility of harmonizing health technology assessments across jurisdictions: a case study of drug eluting stents.
Trueman P; Hurry M; Bending M; Hutton J
Int J Technol Assess Health Care; 2009 Oct; 25(4):455-62. PubMed ID: 19845975
[TBL] [Abstract][Full Text] [Related]
36. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S
Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060
[TBL] [Abstract][Full Text] [Related]
37. INTRODUCTION OF HEALTH TECHNOLOGY ASSESSMENT FOR MEDICINES IN SLOVAKIA.
Tesar T; Hloska A; Wawruch M; Lehocka L; Snopkova M; Masarykova L
Int J Technol Assess Health Care; 2017 Jan; 33(3):345-349. PubMed ID: 28434416
[TBL] [Abstract][Full Text] [Related]
38. PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.
Abelson J; Wagner F; DeJean D; Boesveld S; Gauvin FP; Bean S; Axler R; Petersen S; Baidoobonso S; Pron G; Giacomini M; Lavis J
Int J Technol Assess Health Care; 2016 Jan; 32(4):256-264. PubMed ID: 27670693
[TBL] [Abstract][Full Text] [Related]
39. [Foundations for the institutionalization of health technology assessment in Chile].
Castillo-Riquelme M; Santelices C E
Rev Med Chil; 2014 Jan; 142 Suppl 1():S50-4. PubMed ID: 24861181
[TBL] [Abstract][Full Text] [Related]
40. Tackling ethical issues in health technology assessment: a proposed framework.
Burls A; Caron L; Cleret de Langavant G; Dondorp W; Harstall C; Pathak-Sen E; Hofmann B
Int J Technol Assess Health Care; 2011 Jul; 27(3):230-7. PubMed ID: 21736860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
